Menora Mivtachim Holdings’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Menora Mivtachim Holdings’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-808,073	Closed	-$24.2M	–	89
2017 Q2	$24.2M	Buy	808,073 +126,517	+19%	+$3.28M	1.13%	35
2017 Q1	$18.1M	Buy	681,556 +103,582	+18%	+$2.57M	0.92%	37
2016 Q4	$12.8M	Sell	577,974 -12,750	-2%	-$239K	0.66%	41
2016 Q3	$10.9M	Hold	590,724	–	–	0.6%	41
2016 Q2	$9.6M	Buy	590,724 +400,000	+210%	+$6.74M	0.54%	38
2016 Q1	$2.69M	Buy	+190,724	New	+$2.58M	0.16%	55
2015 Q4	–	Sell	-109,826	Closed	-$2.27M	–	77
2015 Q3	$2.27M	Buy	109,826 +3,126	+3%	+$64.1K	0.17%	50
2015 Q2	$1.64M	Buy	+106,700	New	+$1.5M	0.12%	53

Other funds holding NDRM

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

CFIC

City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

Menora Mivtachim Holdings's NDRM Position: Q3 2017 in Review

Menora Mivtachim Holdings sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2017, closing a stake of 808,073 shares — an estimated $24.2M sold.

Menora Mivtachim Holdings first reported a position in NDRM in Q2 2015 and held it in 8 quarters. The position peaked at $24.2M in Q2 2017. 81 funds tracked by Wall St. Rank hold NDRM as of Q3 2017.

Menora Mivtachim Holdings reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Menora Mivtachim Holdings sold 808,073 NeuroDerm Ltd. Ordinary Shares shares in Q3 2017, an estimated $24.2M.
Menora Mivtachim Holdings first reported a position in NeuroDerm Ltd. Ordinary Shares in Q2 2015 and held it in 8 quarters.
Menora Mivtachim Holdings's NeuroDerm Ltd. Ordinary Shares position peaked at $24.2M in Q2 2017.
81 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2017.

Based on Menora Mivtachim Holdings's 13F filing for Q3 2017, filed 30 Oct 2017.